drugset / Trial / NCT00054600

Safety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-versus-Host Disease

NCT00054600

Phase 2 Completed 60 enrolled Mallinckrodt
Non-randomizedSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to determine whether Extracorporeal Photopheresis with UVADEX (ECP) prior to bone marrow or peripheral blood stem cell transplantation is effective in the prevention of Graft-versus-Host Disease (GvHD).

Timeline

Start
2002-06
Primary completion
Completion
2004-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Methoxsalen Other / unclassified